Year: 2025

The ad hoc committee established by the WashU Board of Trustees to review the university’s policies and guidelines governing on-campus protests and demonstrations has completed its work.

Wilmetta Toliver-Diallo never stops her work on behalf of students. When she is not helping students apply for competitive fellowships, she is lecturing in the Department of African and African American Studies. And when she is not mentoring Mellon Mays fellows, she’s co-hosting dinners for her neighbors on the South 40.

Rob Bilott, the attorney who exposed DuPont’s water contamination cover-up, will speak April 7 for the Assembly Series. “Dark Waters,” a film based on his fight for justice, screens in advance.

Scientists at WashU Medicine have identified a key component to launching immune activity and overactivity, providing a potential therapeutic target for autoimmune diseases.

The Office of Human Resources has a new initiative to spotlight staff members doing amazing work and to help build connections among employees.

Images from on and around the WashU campuses.

The WUSTL Key will take on a different look Tuesday, March 18, as part of efforts to update WashU branding. Log-in details and access will remain the same.

Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.

William D. Owens, MD, a highly regarded professor emeritus of anesthesiology and former head of the Department of Anesthesiology at Washington University School of Medicine, died of cancer Jan. 3.

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.